QIAGEN today announced the inclusion of the QIAcuityDx digital PCR System in the Australian Register of Therapeutic...
Genomics-driven cancer prevention, testing and treatment strategies will be at the forefront of a new joint venture betw...
Philips, a global leader in health technology, and Edith Cowan University Australia (ECU) have announced a new strategic...
Getz Healthcare Australia has announced a strategic distribution agreement with IGEA Medical to introduce the Cliniporat...
The Albanese Government is establishing a new national body to provide leadership, coordination and expertise so all A...
AusBiotech, Australia’s leading national industry body representing more than 3,000 life sciences members, and Lif...
GenScript Biotech Corporation, a global leader in life sciences services and products, has announced the establishment o...
In a recent conversation with Ankit Kankar from BioSpectrum Asia, Yvonne Lungershausen, CEO of Avance Clinical, shared i...
The University of Melbourne and France's National Centre for Scientific Research (CNRS) will establish a new Internation...
AusBiotech, Australia’s leading national industry body representing more than 3,000 life sciences members, and Lif...
Australia-based Monash University’s Faculty of Information Technology has partnered with Apollo Hospitals - one of...
Biomedical engineers from the University of Melbourne, Australia have invented a 3D printing system, or bioprinter, capa...
The Albanese Government is investing $10.3 million to tackle the most common cancer in the sunburnt country, skin cancer...
What was the rationale behind choosing Vietnam as the location for this institute, and how does the country’s acad...
Tell us about Noxopharm and its portfolio of innovative treatments. We are an Australian biotech with two highly ...
Could you explain more about the advantages of using iPSCs from cord blood for creating your ‘off-the-shelf’...
Avance Clinical, a leading full-service Contract Research Organization (CRO), has announced three pivotal Memorandums of...
Australia-based Vaxxas, a clinical-stage biotechnology company commercialising a novel high-density microarray patc...
